Page 4 - Results Compared News Today

/PRNewswire/ -- KLX Energy Services Holdings, Inc. (Nasdaq: KLXE) ("KLXE" or the "Company") today reported financial results for the first quarter ended March...

– Fast Track designation received for PRGN-3006 UltraCAR-T®, an important milestone for patients with relapsed or refractory acute myeloid leukemia, a rapidly...

MONACO, April 28, 2022 (GLOBE NEWSWIRE) -- Scorpio Tankers Inc. (NYSE: STNG) ("Scorpio Tankers" or the "Company") today reported its results for the...

Scorpio Tankers Inc. reported its results for the three months ended March 31, 2022. The Company also announced that its Board of Directors has declared a quarterly cash dividend of $0.10 per share on the Company’s common stock. Results for the three months ended March 31, 2022 and 2021 For the three months ended March ...

Total revenue of $26.6 million in the fourth quarter and $81.7 million for the full yearFINTEPLA® net product sales of $23.5 million in the fourth quarter and $74.7 million for the full year Announced

Scorpio Tankers Inc. reported its results for the three months and year ended December 31, 2021. The Company also announced that its Board of Directors has declared a quarterly cash dividend of $0.10 per share on the Company’s common stock. Results for the three months ended December 31, 2021 and 2020 For the three months ...

/PRNewswire/ - Canada Nickel Company Inc. ("Canada Nickel" or the "Company") (TSXV: CNC) (OTCQX: CNIKF) is pleased to announce further results of metallurgical...

Highlights: Flowsheet improvements yield recovery gains and enhanced magnetite concentrate quality model) Nickel recovery of 62% – 10 percentage points or 19% improvement Iron recovery of 45% - 2 percentage points or 5% improvement Magnetite concentrate grade of 54% iron – 6.5 percentage points or 14% improvement Cobalt recovery of 70% - 30 percentage points or 75% improvement Canada Nickel Company Inc. is ...

Precigen Reports First Quarter 2021 Financial Results - Company on track to achieve stated 2021 milestones - - Initiated Phase 2 clinical trial of PRGN-2009 AdenoVerse™ immunotherapy - - Initiated Phase 1 clinical trial of PRGN-2012 AdenoVerse immunotherapy in patients with recurrent respiratory papillomatosis (RRP) - - Upcoming presentation at FOCIS Virtual Annual Meeting to provide clinical progress for AG019 ActoBiotics™ in Type 1 diabetes (T1D) - News provided by Share this article Shar...

Press release content from Business Wire. The AP news staff was not involved in its creation. Cable One Reports Fourth Quarter and Full Year 2020 Results February 25, 2021 GMT PHOENIX--(BUSINESS WIRE)--Feb 25, 2021-- Cable One, Inc. (NYSE: CABO) (the “Company” or “Cable One”) today reported financial and operating results for the quarter and year ended December 31, 2020. Cable One completed the acquisitions of Fidelity Communications Co.’s data, video and voice business and certain re...